SEC Form D private-offering filing

MOAT BIOTECHNOLOGY Corp

Name: MOAT BIOTECHNOLOGY Corp - new SEC Form D private-offering filing, Oklahoma City, OK
Published: 2025-10-20

A new SEC Form D private-offering notice from Oklahoma City, OK, a $15,593,738 filer-stated offering target in Biotech. The source filing is one click away.

MOAT BIOTECHNOLOGY Corp Verified via SEC Form D

Clinical stage biopharmaceutical company developing intranasal and inhaled adenovirus vaccines using the SC AdVax platform licensed from Mayo Clinic, based in Oklahoma City.

Filed 2025-10-20Filed to raise $15,593,738First money in 2025-10-03Raised so far $26,400HQ (as filed) Oklahoma City, OKSector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Named in the filing 5 executives & directors

Open this row on the live feed →More new filings in Oklahoma →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.